Aimei Total Current Assets from 2010 to 2026

AFJK Stock   57.30  2.98  4.94%   
Aimei Health Total Current Assets yearly trend continues to be quite stable with very little volatility. The value of Total Current Assets are projected to decrease to about 26 K. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2010-12-31
Previous Quarter
27.3 K
Current Value
26 K
Quarterly Volatility
217.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aimei Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aimei Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 159.9 K, Other Operating Expenses of 1.3 M or Total Operating Expenses of 1.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.06. Aimei financial statements analysis is a perfect complement when working with Aimei Health Valuation or Volatility modules.
Check out the analysis of Aimei Health Correlation against competitors.

Latest Aimei Health's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Aimei Health Technology over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Aimei Health's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aimei Health's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Aimei Total Current Assets Regression Statistics

Arithmetic Mean483,162
Geometric Mean339,747
Coefficient Of Variation44.96
Mean Deviation160,680
Median580,717
Standard Deviation217,231
Sample Variance47.2B
Range554.7K
R-Value(0.66)
Mean Square Error28.3B
R-Squared0.44
Significance0
Slope(28,464)
Total Sum of Squares755B

Aimei Total Current Assets History

202626 K
202527.3 K
202430.4 K

About Aimei Health Financial Statements

Aimei Health investors utilize fundamental indicators, such as Total Current Assets, to predict how Aimei Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Assets27.3 K26 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Aimei Health Technology is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Aimei Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Aimei Health Technology Stock. Highlighted below are key reports to facilitate an investment decision about Aimei Health Technology Stock:
Check out the analysis of Aimei Health Correlation against competitors.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aimei Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
0.2
Return On Assets
(0.01)
The market value of Aimei Health Technology is measured differently than its book value, which is the value of Aimei that is recorded on the company's balance sheet. Investors also form their own opinion of Aimei Health's value that differs from its market value or its book value, called intrinsic value, which is Aimei Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aimei Health's market value can be influenced by many factors that don't directly affect Aimei Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aimei Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aimei Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aimei Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.